Rates* of reported cases† of acute hepatitis C, by age group — United States, 2007–2022
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population. Beginning in 2021, single-race population estimates are used for rate calculations. For prior years, bridged-race population estimates are used.
† Reported confirmed cases. For the case definition, see Acute Hepatitis C.
From 2010–2018, rates of reported cases of acute hepatitis C consistently increased among all age groups 20 years and older. However, since 2018, rates among persons aged 20–29 years have been steadily decreasing — the rate in 2022 (2.2 cases per 100,000 population) represents a 27% decrease from the rate in 2018 (3.0 cases per 100,000 population). During 2022, rates of reported cases of acute hepatitis C also decreased among persons aged 40–49 years and 60 years and older; remained stable among persons aged 0–19 years and 50–59 years; and increased among persons aged 30–39 years. During 2022, the rate of reported cases of acute hepatitis C remained highest among persons aged 30–39 years (3.6 cases per 100,000 population), followed by persons aged 20–29 years and 40–49 years (2.2 cases per 100,000 population), similar to age groups with the highest rates of fatal overdose in the United States.1 Rates have consistently been lowest among those aged less than 20 years or 60 years and older.
Source:
- Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001 – 2021. NCHS Data Brief, no 457. Hyattsville, MD: National Center for Health Statistics. 2022. DOI: https://dx.doi.org/10.15620/cdc:122556
- Figure 3.1. Number of reported cases and estimated infections of acute hepatitis C — United States, 2015–2022
- Figure 3.2. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
- Figure 3.3. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2022
- Figure 3.4. Rates of reported cases of acute hepatitis C, by age group — United States, 2007–2022
- Figure 3.5. Rates of reported cases of acute hepatitis C, by sex — United States, 2007–2022
- Figure 3.6. Rates of reported cases of acute hepatitis C, by race/ethnicity — United States, 2007–2022
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C — United States, 2022
- Figure 3.8. Number of newly reported chronic hepatitis C cases by sex and age — United States, 2022
- Figure 3.9. Rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C, by demographic characteristics — United States, 2018–2022
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C — United States, 2022
- Table 3.4. Number of newly reported cases of perinatal hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C, by demographic characteristics — United States, 2022
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 3.8. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022